Entrada Therapeutics, Inc. (TRDA) SEC Filings — 2024
12 SEC filings for Entrada Therapeutics, Inc. (TRDA) in 2024.
Filings
- Entrada Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Entrada Therapeutics Q3 2024: $418M Assets — 10-Q · Nov 5, 2024
- Entrada Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Baker Bros. Advisors Amends Entrada Therapeutics Stake — SC 13D/A · Jun 26, 2024
- Roche Acquires Entrada Therapeutics for $4.3 Billion — 8-K · Jun 24, 2024
- Entrada Therapeutics Files 8-K on Bylaws and Shareholder Votes — 8-K · Jun 13, 2024
- Entrada Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Entrada Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
- Entrada Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 13, 2024
- Entrada Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Entrada Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Entrada Therapeutics 8-K Signals Potential Leadership/Comp Changes — 8-K · Jan 3, 2024